Login
Toggle navigation
Videos
Categories
Trending
The CEO of Freenet AG discusses the company's strategic ambitions in an interview
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Musgrave Minerals: Advancing High-Grade Gold Discoveries in Western Australia
00:10:00
Pioneering prediction and prevention in dermatology|Pia Renaudin, CEO,SciBase Holdings
00:10:00
Revolutionize Your Retirement: Discover AIO Financial's Free Planning App Today | Bill Holliday - Certified Financial Planner (CFP) of AIO Financial, LLC
00:10:00
Global Financial Strategies and Market Insights with Alexander | Alexander, Analyst, WCM Investment Management
00:10:00
Join Cornwall Trade and Investment for a Dynamic Global Career
00:10:00
Lakeside Wealth Management, LLC provides financial planning services.|Jared Hoole is the President of Lakeside Financial Planning
00:10:00
Jeffries' Profit Drop Signals Potential Sector-Wide Challenges
00:00:00
Sacha Loiseau, Ph.D. Chief Executive Officer, Mauna Kea Technologies
00:10:00
Raphaël Sanchez President of Generix Group.
00:10:00
Robert Isom, CEO of American Airlines, at Skift Aviation Forum 2023: Insights from Ft. Worth, Texas | Robert Isom, CEO, American Airlines Group Inc.
00:10:00
Vijay Chandok of ICICI Securities discusses the sustained growth in derivatives income and initiatives to expand the business on ET NOW.
00:10:00
Justice Resources: High-Grade Gold Discovery in Senegal's Orogenic Gold Belt